Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nice attack study reveals hidden toll on hospital heroes

NCT ID NCT03353805

Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at the mental health of hospital staff and medical students after the 2016 Nice terrorist attack. Researchers surveyed 804 people to understand how the event affected them and to find better ways to support caregivers in future crises. The goal was to learn, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

804 people

The number who actually took part.

Started

Jun 2017

Finished

Oct 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The staff * From the establishments of the Nice University Hospital: Hôpital Pasteur, Hôpital l' Archet, Hôpital de Cimiez, Hôpital St Roch, Unité centrale de production or UCP, Hôpital de Tende. * From the Lenval Hospital building: staff of the Nice CHU-Lenval Children's Hospital, and staff of the Lenval Foundation. * Students (external from M1 onwards, i. e. the 4th year, and interns) enrolled in Nice-Sophia Antipolis Faculty of Medicine.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* inclusion criteria: hospital staff Whether or not directly involved in the attack of 14 July 2016. * exclusion criteria: non hospital staff

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mental disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

mental disorder psychiatric disorder Psychological Trauma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mental disorders Psychological trauma

Contacts and locations

Locations

  • Nice Hospital

    Nice, 06000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.